Methylphenidate (Ritalin LA): a second controlled-release formulation PBS listed for attention deficit hyperactivity disorderMethylphenidate (Ritalin LA): a second controlled-release formulation PBS listed for attention deficit hyperactivity disorder

Published 2008-04-01 00:00:00

A second controlled-release formulation of the psychostimulant methylphenidate (Ritalin LA) was listed on the Pharmaceutical Benefits Scheme (PBS) on 1 April 2008. The Pharmaceutical Benefits Advisory Committee (PBAC) agreed that Ritalin LA and the previously listed controlled-release formulation (Concerta) are similarly effective for a similar cost.1

The restricted listing allows Ritalin LA to be prescribed for patients aged 6 to 18 years inclusive for attention deficit hyperactivity disorder (ADHD).1 The patient must have previously responded to the immediate-release formulation of methylphenidate (Ritalin) without serious adverse events. Relevant State and Territory regulations must also be followed when prescribing psychostimulants.

Immediate-release methylphenidate should be used for initial dose titration before switching to an equivalent dose of the controlled-release formulation.2 A once-daily dose of Ritalin LA is similar to twice-daily dosing with immediate-release methylphenidate (a once-daily dose of Concerta is equivalent to three-times-daily dosing). Half of the Ritalin LA dose is released immediately and the other half about 4 hours later, eliminating the need for taking medication at school.3

References

  1. Pharmaceutical Benefits Advisory Committee. November 2007 PBAC outcomes — positive recommendations. 2007. http://www.health.gov.au/internet/main/publishing.nsf/Content/pbacrec-Nov07-positive (accessed 20 February 2008).
  2. Psychotropic Writing Group. Psychotropic. In: eTG complete [CD-ROM]. Melbourne: Therapeutic Guidelines Limited, 2004.
  3. Novartis Pharmaceuticals Pty Ltd. Ritalin 10/Ritalin LA product information. 6 March 2007. Australia.
RSS FeedRSS feed

Date published: 2008-04-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.